227 related articles for article (PubMed ID: 26747505)
1. β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.
Limberg JK; Johansson RE; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Schrage WG
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H756-64. PubMed ID: 26747505
[TBL] [Abstract][Full Text] [Related]
2. Preserved β-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase.
Limberg JK; Johansson RE; Carter KJ; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Walker BJ; Schrage WG
Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H25-H35. PubMed ID: 34738833
[TBL] [Abstract][Full Text] [Related]
3. Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase.
Kellawan JM; Johansson RE; Harrell JW; Sebranek JJ; Walker BJ; Eldridge MW; Schrage WG
Eur J Appl Physiol; 2015 Aug; 115(8):1735-46. PubMed ID: 25820143
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men.
Fujii N; McNeely BD; Kenny GP
J Physiol; 2017 Feb; 595(4):1173-1184. PubMed ID: 27779753
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins do not contribute to the nitric oxide-mediated compensatory vasodilation in hypoperfused exercising muscle.
Casey DP; Joyner MJ
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H261-8. PubMed ID: 21536852
[TBL] [Abstract][Full Text] [Related]
6. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
7. Sex-differences in cholinergic, nicotinic, and β-adrenergic cutaneous vasodilation: Roles of nitric oxide synthase, cyclooxygenase, and K
Fujii N; McGarr GW; Ghassa R; Schmidt MD; McCormick JJ; Nishiyasu T; Kenny GP
Microvasc Res; 2020 Sep; 131():104030. PubMed ID: 32531353
[TBL] [Abstract][Full Text] [Related]
8. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins and nitric oxide mediate insulin-induced vasodilation in the human forearm.
van Veen S; Chang PC
Cardiovasc Res; 1997 Apr; 34(1):223-9. PubMed ID: 9217894
[TBL] [Abstract][Full Text] [Related]
10. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
Hypertension; 1997 Oct; 30(4):918-21. PubMed ID: 9336393
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.
Dawes M; Chowienczyk PJ; Ritter JM
Circulation; 1997 May; 95(9):2293-7. PubMed ID: 9142007
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ATP-mediated vasodilation in humans: modest role for nitric oxide and vasodilating prostaglandins.
Crecelius AR; Kirby BS; Richards JC; Garcia LJ; Voyles WF; Larson DG; Luckasen GJ; Dinenno FA
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1302-10. PubMed ID: 21784984
[TBL] [Abstract][Full Text] [Related]
13. Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women.
Parker BA; Tschakovsky ME; Augeri AL; Polk DM; Thompson PD; Kiernan FJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1118-26. PubMed ID: 21642502
[TBL] [Abstract][Full Text] [Related]
14. Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans.
Schrage WG; Wilkins BW; Johnson CP; Eisenach JH; Limberg JK; Dietz NM; Curry TB; Joyner MJ
J Appl Physiol (1985); 2010 Sep; 109(3):768-77. PubMed ID: 20558755
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans.
Markwald RR; Kirby BS; Crecelius AR; Carlson RE; Voyles WF; Dinenno FA
J Physiol; 2011 Apr; 589(Pt 8):1979-90. PubMed ID: 21486803
[TBL] [Abstract][Full Text] [Related]
16. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia.
Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ
J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358
[TBL] [Abstract][Full Text] [Related]
17. Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature.
Majmudar NG; Anumba D; Robson SC; Ford GA
Br J Clin Pharmacol; 1999 Feb; 47(2):173-7. PubMed ID: 10190652
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.
Kamper AM; de Craen AJ; Westendorp RG; Blauw GJ
Vasc Health Risk Manag; 2005; 1(3):251-6. PubMed ID: 17319111
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
